21-Jul-16 Singapore's biggest healthcare provider Raffles Medical Group will spend SGD1 bn (USD737 mn) over the next three years to set up hospitals and clinics in Asia, group chairman and co-founder Loo Choon Yong said. About SGD600 mn will be used to spur growth outside Singapore, particularly in China, where an ageing population and reforms are expected to boost demand. [image: Raffles Medical Group/ST File]

19-Jul-16 India's government is planning to table a new Medical Device Act in the forthcoming winter session of Parliament. In a 11-Jul-16 meeting on the Make in India initiative for medical devices, attended by leading associations, issues such as ease of doing business, regulation, fiscal imperatives, scaling manufacturing, promoting exports, encouraging innovations and making India attractive for investment were discussed. [image: Business Standard]

14-Jul-16 US multinational drug maker Pfizer is laying down a new foundation in Russia, with a JV to produce pharmaceuticals domestically. Pfizer’s announcement is a plus for Russian businesses, and for sentiment, insofar as it shows the country is still open to Western-backed multinationals. [image: Don Emmert / AFP / Getty Images]

05-Jul-16 Malaysian inpatient admissions appear finally to have turned around in the first quarter of 2016 after three consecutive quarters of decline, with IHH Healthcare Bhd up 10% year-on-year and KPJ Healthcare Bhd up 4%. The turnaround suggests that the drag on healthcare business volume from the implementation of the goods and services tax has finally worn off. [image: Bloomberg / Affin Hwang forecasts]

01-Jul-16 Biotechnology is one of seven strategic industries that the Chinese government designated in the 13th Five-Year Plan. "Made in China 2025", an initiative to upgrade industry, also designates biotechnology as a key industry to push economic development. China's bio-pharmaceutical market is expected to reach USD601 bn by 2020. [image: China Daily]